Veiga-Gil Leonor, López-Olaondo Luis, Pueyo Javier, Callejas Raquel, Duque Paula, Carrascosa Francisco
Departamento de Anestesia y Reanimación, Complejo Hospitalario de Navarra, Pamplona, España.
Departamento de Anestesia, Reanimación y Cuidados Intensivos, Clínica Universidad de Navarra, Pamplona, España.
Cir Esp. 2015 Feb;93(2):110-6. doi: 10.1016/j.ciresp.2014.01.011. Epub 2014 Mar 12.
In this observational study we reviewed the efficacy and side effects of different antiemetic combinations used in our hospital for postoperative nausea and vomiting (PONV) prophylaxis in high-risk women undergoing highly emetogenic surgery.
After reviewing retrospectively the medical records of patients undergoing highly emetogenic elective surgeries under general anaesthesia, we selected 368 women whose Apfel risk score was ≥ 3 and receiving a combination of 2 antiemetics for PONV prophylaxis. We analysed the incidence of PONV at 2, 6, 12 and 24h after surgery, antiemetic rescue requirements, pattern of occurrence of PONV, side effects and level of sedation were also assessed. The main goal was complete response defined as no PONV within 24h after surgery.
Ondansetron 4mg i.v. plus dexamethasone 8mg i.v. (O&Dex), haloperidol 1mg i.v. (O&Hal1), haloperidol 2mg i.v. (O&Hal2) or droperidol 1.25mg i.v. (O&Dro) were the combinations most frequently used. The complete response was better in groups O&Dex: 68.5% (CI: 58-78), O&Hal2: 64.1% (CI: 53-74) and O&Dro 63% (CI: 52-73) than in group O&Hal1: 41.3% (CI: 31-52) (p<0,01). Peak incidence of PONV occurred within the 2-6h period. The incidence of side effects was higher in group O&Hal2.
In high risk patients for PONV who underwent highly emetogenic surgeries, the efficacy of low-dose haloperidol (1mg) in combination is limited. Higher doses (2mg) are more effective but its use is associated with a high incidence of side effects.
在这项观察性研究中,我们回顾了我院用于预防高致吐性手术高危女性术后恶心呕吐(PONV)的不同止吐联合用药的疗效和副作用。
回顾性分析接受全身麻醉下高致吐性择期手术患者的病历后,我们选择了368名Apfel风险评分≥3且接受两种止吐药联合预防PONV的女性。我们分析了术后2、6、12和24小时PONV的发生率,还评估了止吐药的补救需求、PONV的发生模式、副作用和镇静水平。主要目标是完全缓解,定义为术后24小时内无PONV。
最常用的联合用药是静脉注射4mg昂丹司琼加静脉注射8mg地塞米松(O&Dex)、静脉注射1mg氟哌啶醇(O&Hal1)、静脉注射2mg氟哌啶醇(O&Hal2)或静脉注射1.25mg氟哌利多(O&Dro)。O&Dex组(68.5%,CI:58 - 78)、O&Hal2组(64.1%,CI:53 - 74)和O&Dro组(63%,CI:52 - 73)的完全缓解情况优于O&Hal1组(41.3%,CI:31 - 52)(p<0.01)。PONV的高峰发生率出现在2 - 6小时内。O&Hal2组的副作用发生率较高。
在接受高致吐性手术的PONV高危患者中,低剂量氟哌啶醇(1mg)联合用药的疗效有限。高剂量(2mg)更有效,但使用时副作用发生率较高。